American Gastroenterological Association opts for virtual trial kit

Digital-toolkit-aids-decentralized-GI-clinical-trials.jpg
(magicmine/iStock via Getty Images Plus) (Getty Images/iStockphoto)

The medical organization has selected Rx.Health's TrialEngage, a set of digital tools geared toward supporting and improving decentralized trials.

Health technology company Rx.Health is working with the American Gastroenterological Association (AGA) and Precision Research to implement the company’s TrialEngage digital toolkit. According to the Rx.Health, the collaboration will help expand the company’s registry partners and work toward creating a nationwide clinical trial network.

TrialEngage is intended to enhance clinical engagement by supporting research engagement in registries, virtual and decentralized trials, care pathways and the collection of real world evidence and digital biomarkers for investigators, pharma firms and contract research organizations (CROs). According to the company, the platform has a patient activation rate of 92% and a clinician system usability score of 93%.

Chantal Fremont, vice president of practice and quality at the AGA, said the technology stands to help the association in its work to help GI patients and their caregivers.

AGA's mission is to empower clinicians and researchers to improve digestive health. RxHealth and TrialEngage are practical tools that support our work by bringing together the GI community to collaborate on clinical trials that can shape the way we care for patients in the future," she said.

Gaurav Narang, vice president of strategy at Rx.Health, said tools that support patient engagement, like TrialEngage, are especially important in the face of the COVID-19 pandemic.

Working within the EHR, the TrialEngage platform allows bulk digital prescriptions to be sent to large patient cohorts,” he said. “This capability was used to outreach 1m New Yorkers during the COVID crisis and recruit over 55,000 participants.”

Using text to enroll, bots and no-app televisits makes recruiting and engaging trial participants an automated and hands-off process,” Narang added. “It's a pretty unique feature that brings best of clinical outreach and research engagement under one umbrella."

Chris Fourment, president of GI research consortium Precision Research, said the team is confident the TrialEngage platform will serve to improve patient recruitment.

TrialEngage uses text messaging, bots, videos and other information to allow potential participants to engage in the recruitment and follow up process on their own terms. Rx.Health has a deep clinical background in GI and that is certainly another plus,” Fourment said.